Revenue | ₹37.58Cr |
Net Profits | ₹7.79Cr |
Net Profit Margins | 20.73% |
Jenburkt Pharmaceuticals Ltd’s revenue jumped 10.72% since last year same period to ₹37.58Cr in the Q1 2025-2026. On a quarterly growth basis, Jenburkt Pharmaceuticals Ltd has generated -12.46% fall in its revenue since last 3-months.
Jenburkt Pharmaceuticals Ltd’s net profit jumped 4.99% since last year same period to ₹7.79Cr in the Q1 2025-2026. On a quarterly growth basis, Jenburkt Pharmaceuticals Ltd has generated -8.78% fall in its net profits since last 3-months.
Jenburkt Pharmaceuticals Ltd’s net profit margin fell -5.18% since last year same period to 20.73% in the Q1 2025-2026. On a quarterly growth basis, Jenburkt Pharmaceuticals Ltd has generated 4.2% jumped in its net profit margins since last 3-months.
The revenue for Jenburkt Pharmaceuticals Ltd in the Q1 results 2025 was ₹37.58Cr.
The net profit for Jenburkt Pharmaceuticals Ltd in the Q1 results 2025 was ₹7.79Cr.
The net profit margin for Jenburkt Pharmaceuticals Ltd in the Q1 results 2025 was 20.73%.
The revenue for Jenburkt Pharmaceuticals Ltd in the Q1 results 2024 was ₹33.94Cr.
The net profit for Jenburkt Pharmaceuticals Ltd in the Q1 results 2024 was ₹7.42Cr.
The net profit margin for Jenburkt Pharmaceuticals Ltd in the Q1 results 2024 was 21.86%.